Alex Trombetta

Principal @ Initiate Ventures | MBA/MPH @ UC Berkeley

📍 United States🔄 Updated September 2026💼 1 investments📅 4 years investing🗓 Last invested Nov 2022
VC🌍 United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Venture Partner
Nov 2022
A fund for students & alumni to invest in some of the most innovative startups at UC Berkeley.
Experience · 6 entries
All (6)
Investments (1)
Founder (2)
2022
Investor & Venture Partner
Nov 2022
A fund for students & alumni to invest in some of the most innovative startups at UC Berkeley.
Principal
Apr 2022
INITIATE funds and co-creates transformational companies - We focus on bold ideas at the intersection of healthcare, life sciences and technology - We are entrepreneurs and investors who have founded numerous market-defining companies - We dedicate ourselves to only a few founding teams at a time and commit to their success
Co-Founder, VP of Strategy & Operations
Apr 2022
Macro Trials is the precision research clinical platform, driving increased research velocity and an amplified patient experience to unlock value for all stakeholders in the clinical trial ecosystem. Via its digitally powered infrastructure and "hub-and-spoke" distributed model, Macro partners with pharmaceutical companies, CROs, providers, and health systems to conduct trials for high-value therapeutics. The company’s turnkey platform empowers physicians to participate in groundbreaking research via workflow-native efficiency tools, clinical research personnel and a network of logistic partners. Macro’s clinical trial intelligence platform and proprietary real-world evidence as a service (RWEaaS) product supports life sciences companies in all aspects of therapeutic research, development, and commercialization.
2021
Co-Founder
Sep 2021
Kinometrix empowers frontline clinicians to prevent patient harm by providing them accurate, specific, and real-time risk assessments. Kinometrix is a precision patient safety platform powered by machine learning that uses electronic health record (EHR) data to assess risk for patient harm events. Our patient fall solution K-FRAS automates fall-risk assessment and provides specific risk drivers, allowing resources and interventions to be targeted to where they are needed most.
Flare Capital Scholar Fellowship
Jan 2021
Flare Capital Partners is the leading healthcare venture capital firm advancing innovation-driven companies to improve positive health outcomes, broaden care access, and lower healthcare costs. We partner with exceptional founders solving healthcare’s hardest challenges, supporting each with our deep sector expertise, unparalleled industry resources, and proven access to commercial opportunities. Our team of established investors and senior operating executives has invested in 70+ companies and has nearly $1 billion in assets under management. To learn more about Flare Capital Partners, please visit flarecapital.com or follow us on Twitter @flarecapital.
Show all 6 entries ↓